Masitinib for the Treatment of Severe Mast Cell Activation Syndrome

Clinical trial NCT05449444 · UNKNOWN

Trial details

NCT number: NCT05449444
Sponsor: AB Science
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Mast Cell Activation Syndrome

Start date: 2022-07-01
Primary completion: 2024-12-31
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.